DE69917000D1 - Butorphanol enthaltende formulierungen mit verzögerter freisetzung - Google Patents

Butorphanol enthaltende formulierungen mit verzögerter freisetzung

Info

Publication number
DE69917000D1
DE69917000D1 DE69917000T DE69917000T DE69917000D1 DE 69917000 D1 DE69917000 D1 DE 69917000D1 DE 69917000 T DE69917000 T DE 69917000T DE 69917000 T DE69917000 T DE 69917000T DE 69917000 D1 DE69917000 D1 DE 69917000D1
Authority
DE
Germany
Prior art keywords
butorphanol
delayed release
containing formulas
formulations
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69917000T
Other languages
English (en)
Other versions
DE69917000T2 (de
Inventor
Hung-Chih Chang
Lukchiu Li
Youqui Tian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69917000D1 publication Critical patent/DE69917000D1/de
Publication of DE69917000T2 publication Critical patent/DE69917000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69917000T 1998-02-25 1999-02-25 Butorphanol enthaltende formulierungen mit verzögerter freisetzung Expired - Fee Related DE69917000T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3021798A 1998-02-25 1998-02-25
PCT/US1999/004113 WO1999043300A1 (en) 1998-02-25 1999-02-25 Butorphanol sustained release formulations

Publications (2)

Publication Number Publication Date
DE69917000D1 true DE69917000D1 (de) 2004-06-09
DE69917000T2 DE69917000T2 (de) 2005-04-21

Family

ID=21853121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917000T Expired - Fee Related DE69917000T2 (de) 1998-02-25 1999-02-25 Butorphanol enthaltende formulierungen mit verzögerter freisetzung

Country Status (8)

Country Link
US (1) US6197344B1 (de)
EP (1) EP1056443B1 (de)
JP (1) JP2002504505A (de)
AT (1) ATE265846T1 (de)
AU (1) AU753278B2 (de)
CA (1) CA2321924A1 (de)
DE (1) DE69917000T2 (de)
WO (1) WO1999043300A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680067B2 (en) * 2001-11-26 2004-01-20 Oliver Yoa-Pu Hu Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the same
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
WO2004026256A2 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20080227805A1 (en) * 2007-02-28 2008-09-18 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9364430B2 (en) * 2010-10-29 2016-06-14 Relmada Therapeutics, Inc. Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
US10183018B2 (en) 2015-05-28 2019-01-22 Lumosa Therapeutics Co., Ltd. Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
WO2016189393A1 (en) 2015-05-28 2016-12-01 Lumosa Therapeutics Co., Ltd. Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
US11234974B2 (en) 2015-05-28 2022-02-01 Lumosa Therapeutics Co., Ltd. Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
CN111904928A (zh) * 2019-05-07 2020-11-10 江苏恒瑞医药股份有限公司 一种包含布托啡诺的可注射的药物组合物及其制备方法
CN116818928B (zh) * 2023-04-28 2024-04-19 杭州沐源生物医药科技有限公司 一种酒石酸布托啡诺注射液中杂质的分离检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788478A (fr) 1971-09-08 1973-03-06 Bristol Myers Co Procede de preparation de composes analgesiques
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
US4338324A (en) * 1981-03-17 1982-07-06 Mcneilab, Inc. Analgesic potentiation
US4322427A (en) 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
AU614527B2 (en) * 1987-07-24 1991-09-05 Nexstar Pharmaceuticals, Inc. Opioid analgesic liposomal delivery-release system
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
JP2596255Y2 (ja) 1993-03-23 1999-06-07 ナカミチ株式会社 ディスク再生装置
AU4975996A (en) 1995-02-10 1996-08-27 Matthew A Bergan Method and device for administering analgesics
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters

Also Published As

Publication number Publication date
JP2002504505A (ja) 2002-02-12
EP1056443B1 (de) 2004-05-06
DE69917000T2 (de) 2005-04-21
WO1999043300A1 (en) 1999-09-02
ATE265846T1 (de) 2004-05-15
AU3311299A (en) 1999-09-15
CA2321924A1 (en) 1999-09-02
AU753278B2 (en) 2002-10-10
EP1056443A1 (de) 2000-12-06
US6197344B1 (en) 2001-03-06

Similar Documents

Publication Publication Date Title
DE69917000D1 (de) Butorphanol enthaltende formulierungen mit verzögerter freisetzung
ES2182234T3 (es) Inhibidores de metaloproteasa.
TR200000782T2 (tr) Resorsinol türevleri.
EA200100208A1 (ru) Новая форма соли пантопразола
HN1998000057A (es) Derivados de nicotinamida
CY1107236T1 (el) Παραγωγα της 2-αμινο-3-(αλκυλο)-πυριμιδονης ως gsk3. βητα αναστολεις
MXPA02004556A (es) Soluciones que contienen epinastina.
DK1248867T3 (da) Selektiv elektrokemisk reduktion af halogenerede 4-aminopicolinsyrer
DE60005031D1 (de) Partikel mit kontrollierter freisetzungsrate
MXPA02009313A (es) Acilsulfimidas heterociclicas, un metodo para su produccion, agentes que contienen las mismas y su uso como plaguicidas.
EA200100852A1 (ru) Производные резорцина
AU3565700A (en) Antibacterial agents
DK1100329T3 (da) Vækstregulerende vandige sammensætninger
ATE318825T1 (de) Herstellung von cephalosporin
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
PT1156999E (pt) Metodo para a preparacao de um beta-aminoester quiral
NO20021309D0 (no) Preparat for IVF
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
MX9203486A (es) (quinolin-2-imetoxi)indol como inhibidores de la biosintesis de leucotrienos).
TR200102093T2 (tr) Organ koruyucu çözeltiler
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
UA33865A (uk) Дикалієва сіль n-сукцин - dl-триптофану, що має антиангінальну та антигіпоксантну дію
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.
HN1999000157A (es) 1,2,3 tetrahidroquinolinas 2 - sustituidas 4 - amino sustituidas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee